NKP-1339
Cat. No.:YN270339
CAS No. :197723-00-5
产品名称: | NKP-1339 |
CAS No.: | 197723-00-5 |
Chemical Name: | (OC-6-11)-tetrachlorobis(1H-indazole-κN2)-ruthenate(1-), monosodium salt |
Synonyms: | IT-139; KP-1339 |
分子量: | 502.14 |
分子式: | C₁₄H₁₂Cl₄N₄NaRu |
SMILES: | [Cl-][Ru+3]([N]1=CC2=CC=CC=C2N1)([Cl-])([Cl-])([N]3=CC4=CC=CC=C4N3)[Cl-].[Na+] |
存储: | Please store the product under the recommended conditions in theCertificate of Analysis. |
运输: | Room temperature in continental US; may vary elsewhere. |
产品描述: | NKP-1339 (IT-139; KP-1339) 是针对实体癌开发的一流钌抗癌试剂,副作用小。NKP-1339 通过线粒体途径诱导 G2/M 细胞周期停滞,DNA 合成阻断 (DNA synthesis) 和诱导细胞凋亡 (apoptosis)。NKP-1339 具有很高的肿瘤靶向潜力,与血清蛋白 (serum proteins) 如白蛋白和转铁蛋白强烈结合,并在还原性肿瘤环境中激活。 |
IC50和靶点: | |
In Vitro: | |
In Vivo: | |
Clinical Trial: | |
Solvent & Solubility: |
Kapitza, S., Pongratz, M., Jakupec, M.A., et al.Heterocyclic complexes of ruthenium(III) induce apoptosis in colorectal carcinoma cellsJ. Cancer Res. Clin. Oncol.131(2),101-110(2005)
Hudej, R., Turel, I., Kanduser, M., et al.The influence of electroporation on cytotoxicity of anticancer ruthenium(III) complex KP1339 in vitro and in vivoAnticancer Res.30(6),2055-2063(2010)